TradingKey

關於 Bio Rad Laboratories Inc 公司

Bio-Rad Laboratories, Inc. 致力於爲生命科學研究和臨牀診斷市場開發、製造和營銷一系列產品。該公司提供一系列產品和系統，用於分離複雜的化學和生物材料並識別、分析和純化其成分。該公司通過兩個部門運營：生命科學和臨牀診斷。生命科學部門開發、製造和營銷用於生物研究、生物製藥生產過程、食品檢測制度和科學教育的儀器、系統、試劑和消耗品。其臨牀診斷部門設計、製造、營銷和支持測試系統、信息系統、測試套件和專門的質量控制，爲全球診斷市場的臨牀實驗室提供服務。這些產品銷往醫院實驗室、診斷參考實驗室、輸血實驗室和醫生辦公室實驗室。

公司簡介

公司代碼BIO

公司名稱Bio Rad Laboratories Inc

上市日期Mar 17, 1980

成立日期1975

CEOMr. Norman D. Schwartz

員工數量7700

證券類型Ordinary Share

年結日Mar 17

公司地址1000 Alfred Nobel Dr

城市HERCULES

上市交易所NYSE Consolidated

國家United States of America

郵編94547

電話15107247000

網址https://www.bio-rad.com/

公司代碼BIO

上市日期Mar 17, 1980

成立日期1975

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Norman D. Schwartz

Chairman of the Board, Chief Executive Officer

442.79K

+0.49%

Ms. Colleen Corey

Executive Vice President, Global Human Resources

18.48K

+7.29%

Mr. Michael Crowley

Executive Vice President - Global Commercial Operations

8.17K

--

Mr. Gregory K. (Greg) Hinckley, CPA

Lead Independent Director

808.00

+61.60%

Mr. Sedat Evran

Executive Vice President - Global Supply Chain

729.00

+3545.00%

Mr. Arnold A. Pinkston

Independent Director

308.00

--

Mr. Jeffrey L. (Jeff) Edwards

Independent Director

308.00

--

Ms. Eva Anette Engelhardt

Executive Vice President, President of Clinical Diagnostics Group

157.00

--

Ms. Courtney C Enloe

Executive Vice President, General Counsel, Secretary

119.00

--

Ms. Melinda Litherland

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Norman D. Schwartz

Chairman of the Board, Chief Executive Officer

442.79K

+0.49%

Ms. Colleen Corey

Executive Vice President, Global Human Resources

18.48K

+7.29%

Mr. Michael Crowley

Executive Vice President - Global Commercial Operations

8.17K

--

Mr. Gregory K. (Greg) Hinckley, CPA

Lead Independent Director

808.00

+61.60%

Mr. Sedat Evran

Executive Vice President - Global Supply Chain

729.00

+3545.00%

Mr. Arnold A. Pinkston

Independent Director

308.00

--

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

暫無數據

地區USD

名稱

營收

佔比

United States

241.70M

41.29%

Europe

199.80M

34.13%

APAC

104.10M

17.78%

Other

39.80M

6.80%

業務

地區

暫無數據

股東統計

更新時間: 5月16日週五

持股股東

股東類型

持股股東

佔比

First Eagle Investment Management, L.L.C.

10.36%

The Vanguard Group, Inc.

8.59%

Alice N. Schwartz Revocable Trust

8.04%

BlackRock Institutional Trust Company, N.A.

7.42%

Schwartz (Alice N)

4.29%

Other

61.29%

持股股東

佔比

First Eagle Investment Management, L.L.C.

10.36%

The Vanguard Group, Inc.

8.59%

Alice N. Schwartz Revocable Trust

8.04%

BlackRock Institutional Trust Company, N.A.

7.42%

Schwartz (Alice N)

4.29%

Other

61.29%

股東類型

持股股東

佔比

Investment Advisor/Hedge Fund

42.73%

Investment Advisor

39.24%

Individual Investor

8.14%

Corporation

8.05%

Hedge Fund

5.69%

Research Firm

1.93%

Bank and Trust

1.28%

Pension Fund

1.16%

Sovereign Wealth Fund

0.64%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

1114

24.05M

108.63%

-2.78M

2025Q1

1170

23.54M

106.01%

-2.87M

2024Q4

1159

23.02M

100.37%

-3.90M

2024Q3

1144

23.65M

103.58%

-2.77M

2024Q2

1163

23.92M

102.32%

-878.39K

2024Q1

1175

22.36M

95.71%

-2.57M

2023Q4

1205

22.70M

94.11%

-2.35M

2023Q3

1189

22.91M

95.16%

-1.86M

2023Q2

1192

23.05M

93.93%

-1.30M

2023Q1

1200

23.34M

95.18%

-1.09M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

First Eagle Investment Management, L.L.C.

2.29M

10.36%

+728.07K

+46.49%

Apr 30, 2025

The Vanguard Group, Inc.

1.90M

8.59%

-10.12K

-0.53%

Mar 31, 2025

Alice N. Schwartz Revocable Trust

1.78M

8.04%

-3.19K

-0.18%

Feb 24, 2025

BlackRock Institutional Trust Company, N.A.

1.64M

7.42%

-4.83K

-0.29%

Mar 31, 2025

Schwartz (Alice N)

951.13K

4.3%

+2.20K

+0.23%

Feb 24, 2025

Veritas Asset Management LLP

913.12K

4.12%

-63.70K

-6.52%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

877.04K

3.96%

+130.92K

+17.55%

Mar 31, 2025

Ariel Investments, LLC

724.66K

3.27%

+164.14K

+29.28%

Mar 31, 2025

State Street Global Advisors (US)

694.52K

3.14%

+4.36K

+0.63%

Mar 31, 2025

EARNEST Partners, LLC

599.62K

2.71%

-18.43K

-2.98%

Mar 31, 2025

持股ETF

更新時間: 6 小時前

機構名稱

佔比

Parnassus Value Select ETF

2.78%

VanEck Morningstar ESG Moat ETF

2.29%

First Trust Indxx Medical Devices ETF

1.89%

Alger Russell Innovation ETF

1.78%

ROBO Global Healthcare Technology & Innovation ETF

1.57%

VanEck Morningstar Wide Moat Growth ETF

1.16%

Schwab Ariel Opportunities ETF

1.14%

Pacer US Export Leaders ETF

1.02%

FPA Global Equity ETF

1.01%

First Eagle Global Equity ETF

0.84%

Parnassus Value Select ETF

佔比2.78%

VanEck Morningstar ESG Moat ETF

佔比2.29%

First Trust Indxx Medical Devices ETF

佔比1.89%

Alger Russell Innovation ETF

佔比1.78%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.57%

VanEck Morningstar Wide Moat Growth ETF

佔比1.16%

Schwab Ariel Opportunities ETF

佔比1.14%

Pacer US Export Leaders ETF

佔比1.02%

FPA Global Equity ETF

佔比1.01%

First Eagle Global Equity ETF

佔比0.84%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Bio Rad Laboratories Inc

284.600USD

Bio Rad Laboratories Inc

284.600

概覽

公司

財務